Risk of vascular diseases in patients with dermatitis herpetiformis and coeliac disease: a long-term cohort study

References

• Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):1–10. doi: 10.1016/S0140-6736(17)31796-8.
   PubMed Web of Science ®Google Scholar
• Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017;49(1):23–31. doi: 10.1080/07853890.2016.1222450.
   PubMed Web of Science ®Google Scholar
• Sárdy M, Kárpáti S, Merkl B, et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195(6):747–757. doi: 10.1084/jem.20011299.
   PubMed Web of Science ®Google Scholar
• Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther. 2012;35(6):730–739. doi: 10.1111/j.1365-2036.2012.04998.x.
   PubMed Web of Science ®Google Scholar
• Vasquez H, Mazure R, Gonzalez D, et al. Risk of fractures in celiac disease patients: a cross-sectional, case-control study. Am J Gastroenterol. 2000;95(1):183–189. doi: 10.1111/j.1572-0241.2000.01682.x.
   PubMed Web of Science ®Google Scholar
• Pasternack C, Koskinen I, Hervonen K, et al. Risk of fractures in dermatitis herpetiformis and coeliac disease: a register-based study. Scand J Gastroenterol. 2019;54(7):843–848. doi: 10.1080/00365521.2019.1636132.
   PubMed Web of Science ®Google Scholar
• Nurmi R, Pasternack C, Salmi T, et al. The risk of renal comorbidities in celiac disease patients depends on the phenotype of celiac disease. J Intern Med. 2022;292(5):779–787. doi: 10.1111/joim.13532.
   PubMed Web of Science ®Google Scholar
• Tio M, Cox MR, Eslick GD. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther. 2012;35(5):540–551. doi: 10.1111/j.1365-2036.2011.04972.x.
   PubMed Web of Science ®Google Scholar
• Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis. 2006;38(6):374–380. doi: 10.1016/j.dld.2006.03.002.
   PubMedGoogle Scholar
• Swerdlow AJ, Whittaker S, Carpenter LM, et al. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol. 1993;129(2):140–144. doi: 10.1111/j.1365-2133.1993.tb03516.x.
   PubMed Web of Science ®Google Scholar
• Hervonen K, Alakoski A, Salmi TT, et al. Reduced mortality in dermatitis herpetiformis: a population-based study of 476 patients. Br J Dermatol. 2012;167(6):1331–1337. doi: 10.1111/j.1365-2133.2012.11105.x.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Wijarnpreecha K, Tanratana P. Risk of venous thromboembolism in patients with celiac disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(7):1240–1245. doi: 10.1111/jgh.13282.
   PubMed Web of Science ®Google Scholar
• Heikkilä K, Koskinen OA, Agarwal A, et al. Associations of coeliac disease with coronary heart disease and cerebrovascular disease: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2015;25(9):816–831. doi: 10.1016/j.numecd.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Lebwohl B, Green PHR, Söderling J, et al. Association between celiac disease and mortality risk in a swedish population. JAMA. 2020;323(13):1277–1285. doi: 10.1001/jama.2020.1943.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, James S, Askling J, et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation. 2011;123(5):483–490. doi: 10.1161/CIRCULATIONAHA.110.965624.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, West J, Card T, et al. Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis. 2012;21(8):860–867. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.008.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, De Faire U, Ekbom A, et al. Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease. Heart. 2007;93(9):1111–1115. doi: 10.1136/hrt.2006.097097.
   PubMed Web of Science ®Google Scholar
• West J, Logan RFA, Card TR, et al. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther. 2004;20(1):73–79. doi: 10.1111/j.1365-2036.2004.02008.x.
   PubMed Web of Science ®Google Scholar
• Schneider CV, Kleinjans M, Fromme M, et al. Phenome-wide association study in adult coeliac disease: role of HLA subtype. Aliment Pharmacol Ther. 2021;53(4):510–518. doi: 10.1111/APT.16206.
   PubMed Web of Science ®Google Scholar
• Koskinen I, Hervonen K, Huhtala H, et al. Mortality and causes of death in different celiac disease phenotypes during long-term follow-up. Dig Liver Dis. 2022;54(11):1502–1507. doi: 10.1016/j.dld.2022.04.016.
   PubMedGoogle Scholar
• Koskinen I, Virta LJ, Huhtala H, et al. Overall and Cause-Specific mortality in adult celiac disease and dermatitis herpetiformis diagnosed in the 21st century. Am J Gastroenterol. 2020;115(7):1117–1124. doi: 10.14309/ajg.0000000000000665.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Welander A, Lassila R, et al. Risk of thromboembolism in 14 000 individuals with coeliac disease. Br J Haematol. 2007;139(1):121–127. doi: 10.1111/j.1365-2141.2007.06766.x.
   PubMed Web of Science ®Google Scholar
• Zöller B, Li X, Sundquist J, et al. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379(9812):244–249. doi: 10.1016/S0140-6736(11)61306-8.
   PubMed Web of Science ®Google Scholar
• Johannesdottir SA, Erichsen R, Horváth-Puhó E, et al. Coeliac disease and risk of venous thromboembolism: a nationwide population-based case-control study. Br J Haematol. 2012;157(4):499–501. doi: 10.1111/j.1365-2141.2012.09030.x.
   PubMed Web of Science ®Google Scholar
• Santoro L, De Matteis G, Fuorlo M, et al. Atherosclerosis and cardiovascular involvement in celiac disease: the role of autoimmunity and inflammation. Eur Rev Med Pharmacol Sci. 2017;21(23):5437–5444. doi: 10.26355/eurrev_201712_13932.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim H, Roh H, et al. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res. 2018;41(4):372–383. doi: 10.1007/s12272-018-1016-4.
   PubMed Web of Science ®Google Scholar
• Theethira TG, Dennis M, Leffler DA. Nutritional consequences of celiac disease and the gluten-free diet. Expert Rev Gastroenterol Hepatol. 2014;8(2):123–129. doi: 10.1586/17474124.2014.876360.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA. 2009;302(11):1171–1178. doi: 10.1001/jama.2009.1320.
   PubMed Web of Science ®Google Scholar
• De Marchi S, Chiarioni G, Prior M, et al. Young adults with coeliac disease may be at increased risk of early atherosclerosis. Aliment Pharmacol Ther. 2013;38(2):162–169. doi: 10.1111/apt.12360.
   PubMed Web of Science ®Google Scholar
• Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009;30(4):315–330. doi: 10.1111/j.1365-2036.2009.04053.x.
   PubMed Web of Science ®Google Scholar
• Lewis NR, Sanders DS, Logan RFA, et al. Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment. Br J Nutr. 2009;102(4):509–513. doi: 10.1017/S0007114509297248.
   PubMed Web of Science ®Google Scholar
• Wijarnpreecha K, Lou S, Panjawatanan P, et al. Cigarette smoking and risk of celiac disease: a systematic review and meta-analysis. United European Gastroenterol J. 2018;6(9):1285–1293. doi: 10.1177/2050640618786790.
   PubMed Web of Science ®Google Scholar
• Lerner A, Agmon-Levin N, Shapira Y, et al. The thrombophilic network of autoantibodies in celiac disease. BMC Med. 2013;11(1):89. doi: 10.1186/1741-7015-11-89.
   PubMedGoogle Scholar
• Laine O, Pitkänen K, Lindfors K, et al. Elevated serum antiphospholipid antibodies in adults with celiac disease. Dig Liver Dis. 2018;50(5):457–461. doi: 10.1016/j.dld.2017.11.018.
   PubMedGoogle Scholar
• Kurppa K, Lauronen O, Collin P, et al. Factors associated with dietary adherence in celiac disease: a nationwide study. Digestion. 2012;86(4):309–314. doi: 10.1159/000341416.
   PubMed Web of Science ®Google Scholar
• Sund R. Quality of the finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505–515. doi: 10.1177/1403494812456637.
   PubMed Web of Science ®Google Scholar